A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT06716424
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 105 participants
- Sponsor
- Registry
-
NCT06716424 -
U1111-1303-3494
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT06716424. Allocation not applicable; no masking; primary purpose other. Start 2025-01-06 (actual); primary completion 2026-06-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- iGlarLixi (insulin glargine/lixisenatide)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct06716424- Content hash
dcf439d00050ffcfc3f0e188d104bb67bee3ceff6f7f10d4dc9e03caddb5dc8c